ConductScience.org, home

Library / Genes

SELP: selectin P

1 protein, 76 patents, 5 drugs, 19 trials, 8,198 NIH grants and 21,852 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSELPHGNC
Nameselectin PHGNC
NCBI Gene ID6403NCBI Gene
HGNC IDHGNC:10721HGNC
EnsemblENSG00000174175NCBI Gene
AliasesCD62, CD62P, GMP-140, GMP140, GRMP, LECAM3, PADGEM, PSELNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P16109P-selectin8305Ensembl, GeneID, HGNCUniProt

Patents 76

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1462866P16109Espacenet
JP 2026004568 A2026-01-1462870P16109Espacenet
JP 2026500455 A2026-01-073P16109Espacenet
EP 4641201 A22025-10-291812P16109Espacenet
EP 4608463 A12025-09-033P16109Espacenet
JP 2025517969 A2025-06-121812P16109Espacenet
EP 4484957 A12025-01-01182P16109Espacenet
WO 2023162878 A2023-08-31182P16109Espacenet
US 11708610 B22023-07-25957P16109Espacenet
US 11708610 B22023-07-25958P16109Espacenet

Drugs 5

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
BIMOSIAMOSECHEMBL1215923Selectin inhibitorINHIBITORChEMBL
CRIZANLIZUMABCHEMBL4297734P-selectin blockerBLOCKERChEMBL
INCLACUMABCHEMBL2109488P-selectin antagonistANTAGONISTChEMBL
RG-1512CHEMBL2109487P-selectin inhibitorINHIBITORChEMBL
RIVIPANSELCHEMBL3707446P-selectin antagonistANTAGONISTChEMBL

Trials 19

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT06439082CRIZANLIZUMABPHASE3ClinicalTrials.gov
NCT05909618CRIZANLIZUMABPHASE2ClinicalTrials.gov
NCT05469828CRIZANLIZUMABPHASE1/PHASE2ClinicalTrials.gov
NCT05348915INCLACUMABPHASE3ClinicalTrials.gov
NCT04935879INCLACUMABPHASE32025-12-02ClinicalTrials.gov
NCT04662931CRIZANLIZUMABPHASE42025-01-08ClinicalTrials.gov
NCT04657822CRIZANLIZUMABPHASE4ClinicalTrials.gov
NCT04611880CRIZANLIZUMABPHASE2ClinicalTrials.gov
NCT04435184CRIZANLIZUMABPHASE22021-11-09ClinicalTrials.gov
NCT04097821CRIZANLIZUMABPHASE1/PHASE22025-08-07ClinicalTrials.gov

NIH grants 8198

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant382,025NIH's project files
R01HL101972Characterization of Coagulation Factor-platelet Interactions: Role of FXI282,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award232,025NIH's project files
P30CA016672Cancer Center Support Grant222,025NIH's project files
R01HL103411Systems Biology of Glycosylation162,025NIH's project files
P01CA108671Myeloproliferative Neoplasms-Research Consortium152,025NIH's project files
ZIAHL006001Framingham Project/Levy152,025NIH's project files
P30ES001247Environmental Agents as Modulators of Disease Processes142,025NIH's project files
P51OD011092Support for National Primate Research Center132,025NIH's project files
P30CA014520UW Comprehensive Cancer Center Support122,025NIH's project files

Papers 21852

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42821743PubTator, text miningPubMed
42810688PubTator, text miningPubMed
42809927PubTator, text miningPubMed
42794692PubTator, text miningPubMed
42793169PubTator, text miningPubMed
42788303PubTator, text miningPubMed
42787274PubTator, text miningPubMed
42785691PubTator, text miningPubMed
42784692PubTator, text miningPubMed
42782790PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license